Chargement en cours...
Safety profile of biologic therapy in Polish paediatric patients with Crohn's disease
INTRODUCTION: In recent years, monoclonal antibodies against tumor necrosis factor α (TNF-α), infliximab (IFX), and adalimumab (ADA) have gained increasing popularity in Crohn's disease (CD) management. Many clinical trials have shown that biologics are a generally well-tolerated and safe treat...
Enregistré dans:
| Publié dans: | Prz Gastroenterol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Termedia Publishing House
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4607696/ https://ncbi.nlm.nih.gov/pubmed/26516383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pg.2015.52298 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|